| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/11/1997 | US5610011 Virulence-encoding DNA sequences of Strepococcus suis and related products and methods |
| 03/11/1997 | US5610009 Mammalian expression systems for hepatitis C virus envelope genes |
| 03/11/1997 | US5610008 Method of recovering endothelial membrane from tissue and applications thereof |
| 03/11/1997 | US5609876 Peptide vaccines and associated methods for protection against feline leukemia virus |
| 03/11/1997 | US5609872 Peptides comprising a protective epitope from blood stages of plasmodium falciparum |
| 03/11/1997 | US5609870 Antisecretory, immunology |
| 03/11/1997 | CA2015505C Polyamines and polypeptides useful as antagonists of excitatory amino acid neurotransmitters and/or as blockers of calcium channels |
| 03/11/1997 | CA1338981C Biologically active proteins and a method for their production |
| 03/06/1997 | WO1997008560A1 QUANTITATION OF p97 TO DIAGNOSE AND MONITOR ALZHEIMER'S DISEASE |
| 03/06/1997 | WO1997008558A1 Method for diagnosing onset and maturity of infections |
| 03/06/1997 | WO1997008553A1 Targeting of proteins to the cell wall of gram-positive bacteria |
| 03/06/1997 | WO1997008550A1 Retinoid x receptors and components of the basal transcription machinery |
| 03/06/1997 | WO1997008531A2 Detection of hepatitis gb virus genotypes |
| 03/06/1997 | WO1997008329A1 Plastid inner envelope membrane targeting polypeptides; manufacture and use thereof |
| 03/06/1997 | WO1997008328A1 Selective elimination of t cells that recognize specific preselected targets |
| 03/06/1997 | WO1997008325A2 Purified coprinus laccases and nucleic acids encoding same |
| 03/06/1997 | WO1997008324A1 Methods for enhancing the production of interferon in cell culture |
| 03/06/1997 | WO1997008322A1 Mpt83 gene from mycobacterium tuberculosis |
| 03/06/1997 | WO1997008321A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 03/06/1997 | WO1997008320A1 Protein/(poly)peptide libraries |
| 03/06/1997 | WO1997008319A1 Genetic alterations related to familial alzheimer's disease |
| 03/06/1997 | WO1997008318A2 Compounds and methods for treatment and diagnosis of prostate cancer |
| 03/06/1997 | WO1997008317A2 Human hypothalmic ('hr') receptor polypeptide compositions, methods and uses thereof |
| 03/06/1997 | WO1997008316A1 Mouse integrin subunits |
| 03/06/1997 | WO1997008315A1 Cloning methods for high strength spider silk proteins |
| 03/06/1997 | WO1997008314A2 Telomere repeat binding factor and diagnostic and therapeutic use thereof |
| 03/06/1997 | WO1997008313A1 Variants of vascular endothelial cell growth factor, their uses, and processes for their production |
| 03/06/1997 | WO1997008312A1 Human jtv1 gene overlaps pms2 gene |
| 03/06/1997 | WO1997008311A1 Novel procollagens |
| 03/06/1997 | WO1997008310A1 Novel 3' terminal sequence of hepatitis c virus genome and diagnostic and therapeutic uses thereof |
| 03/06/1997 | WO1997008308A1 Batten disease gene |
| 03/06/1997 | WO1997008307A1 Heterologous protein production system using avian cells |
| 03/06/1997 | WO1997008304A2 Methodology to produce, purify and assay polypeptides with the proteolytic activity of the hcv ns3 protease |
| 03/06/1997 | WO1997008303A1 Transgenic animals expressing diabetogenic t-cell receptor transgenes |
| 03/06/1997 | WO1997008301A1 Novel factors which modify gene transcription and methods of use therefor |
| 03/06/1997 | WO1997008299A1 Overproduction of neuronal nitric oxide synthase |
| 03/06/1997 | WO1997008297A1 Recombinant helicoverpa baculoviruses expressing heterologous dna |
| 03/06/1997 | WO1997008296A1 Method of growing rickettsiae in ixodes scapularis tick cell culture and preparing antigens and vaccines of rickettsiae |
| 03/06/1997 | WO1997008292A1 Methods for enhancing the production of viral vaccines in cell culture by interferon suppression |
| 03/06/1997 | WO1997008203A1 Structural mimics of rgd-binding sites |
| 03/06/1997 | WO1997008202A1 Antisecretory factor peptides regulating pathological permeability changes |
| 03/06/1997 | WO1997008201A1 Autoantibodies in patients with acquired hypoparathyroidism and assay method therefor |
| 03/06/1997 | WO1997008200A1 Erythropoietin binding protein useful for regulation of erythropoiesis and an assay for determination thereof |
| 03/06/1997 | WO1997008199A2 Antimicrobial cationic peptides and methods of screening for the same |
| 03/06/1997 | WO1997008198A1 Antigenic peptide compounds and immunoassay method |
| 03/06/1997 | WO1997008197A1 Dna sequence coding for a polypeptide which enhances virus infection of host insects |
| 03/06/1997 | WO1997008196A1 Neurturin and related growth factors |
| 03/06/1997 | WO1997008195A1 Ubiquitin conjugating enzymes having transcriptional repressor activity |
| 03/06/1997 | WO1997008194A1 Novel fluorescent substrate for assaying activity of hepatitis c virus ns3 serine protease |
| 03/06/1997 | WO1997008193A1 Acylated oligopeptide derivatives having cell signal inhibiting activity |
| 03/06/1997 | WO1997008189A1 Colon cell and colon cancer cell associated nucleic acid molecules, protein and peptides |
| 03/06/1997 | WO1997007828A1 Therapy for cellular accumulation in chronic inflammatory diseases |
| 03/06/1997 | WO1997007827A1 Gab1, A Grb2 BINDING PROTEIN, AND COMPOSITIONS FOR MAKING AND METHODS OF USING THE SAME |
| 03/06/1997 | WO1997007815A2 Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis |
| 03/06/1997 | WO1997007808A1 Chimeric antiviral agents which incorporate rev binding nucleic acids |
| 03/06/1997 | WO1997007665A1 Production of transgenic plants comprising the winged bean lysine- rich protein |
| 03/06/1997 | WO1997005285A3 Methods and compositions for identifying morphogen analogs |
| 03/06/1997 | WO1997005249A3 Extension of a protein-protein interaction surface to inactivate the function of a cellular protein |
| 03/06/1997 | WO1997005159A3 Method for the purification of proteins |
| 03/06/1997 | WO1997002344A3 Vaccine for infectious agents, composition for treating and preventing hiv infections |
| 03/06/1997 | WO1997000329A3 Modified avidin and streptavidin molecules and use thereof |
| 03/06/1997 | WO1996040929A3 Transferrin receptor genes |
| 03/06/1997 | WO1996040768A3 Anti-fungal and anti-bacterial histatin-based peptides |
| 03/06/1997 | WO1996039422A3 Modification of polypeptide drugs to increase electrotransport flux |
| 03/06/1997 | WO1996036354A3 Anticancer vaccine comprising il6/il6 receptor transfected cells |
| 03/06/1997 | WO1994006911A3 Mycoplasma pulmonis antigens and methods and compositions for use in cloning and vaccination |
| 03/06/1997 | CA2666298A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 03/06/1997 | CA2230929A1 Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis |
| 03/06/1997 | CA2230852A1 Therapy for cellular accumulation in chronic inflammatory diseases |
| 03/06/1997 | CA2230689A1 Ubiquitin conjugating enzymes having transcriptional repressor activity |
| 03/06/1997 | CA2230654A1 Genetic alterations related to familial alzheimer's disease |
| 03/06/1997 | CA2230637A1 Retinoid x receptors and components of the basal transcription machinery |
| 03/06/1997 | CA2230239A1 Transgenic animals expressing diabetogenic t-cell receptor transgenes |
| 03/06/1997 | CA2230160A1 Antimicrobial cationic peptides and methods of screening for the same |
| 03/06/1997 | CA2230144A1 Variants of vascular endothelial cell growth factor, their uses, and processes for their production |
| 03/06/1997 | CA2230055A1 Autoantibodies in patients with acquired hypoparathyroidism and assay method therefor |
| 03/06/1997 | CA2229789A1 Human jtv1 gene overlaps pms2 gene |
| 03/06/1997 | CA2229749A1 Chimeric antiviral agents which incorporate rev binding nucleic acids |
| 03/06/1997 | CA2229622A1 Mouse integrin subunits |
| 03/06/1997 | CA2229043A1 Protein/(poly)peptide libraries |
| 03/06/1997 | CA2228820A1 Detection of hepatitis gb virus genotypes |
| 03/06/1997 | CA2227963A1 Novel factors which modify gene transcription and methods of use therefor |
| 03/06/1997 | CA2227516A1 Acylated oligopeptide derivatives having cell signal inhibiting activity |
| 03/05/1997 | EP0760014A1 Identification and use of antiviral compounds |
| 03/05/1997 | EP0760013A1 Treatment of influenza virus infection using antivirals that inhibit acylation/palmitylation of hemagglutinin |
| 03/05/1997 | EP0760008A1 Pna probes for detection of neisseria gonorrhoeae and chlamydia trachomatis |
| 03/05/1997 | EP0759999A1 Process for inhibiting the growth of a culture of lactic acid bacteria, and optionally lysing the bacterial cells, and uses of the resulting lysed culture |
| 03/05/1997 | EP0759995A1 Fusion glycoprotein from hcmv and hsv |
| 03/05/1997 | EP0759989A1 IMPROVED $i(BACILLUS THURINGIENSIS) $g(d)-ENDOTOXIN |
| 03/05/1997 | EP0759988A1 NUCLEIC ACIDS OF $i(ROCHALIMAEA HENSELAE) AND $i(ROCHALIMAEA QUINTANA) AND METHODS AND COMPOSITIONS FOR DIAGNOSING $i(ROCHALIMAEA HENSELAE) AND $i(ROCHALIMAEA QUINTANA) INFECTION |
| 03/05/1997 | EP0759987A1 Human restrictin and nucleic acid sequences |
| 03/05/1997 | EP0759986A1 Diagnostics and treatments for cancers expressing tyrosine phosphorylated crkl protein |
| 03/05/1997 | EP0759985A1 Transgenic arthritic mice |
| 03/05/1997 | EP0759984A1 Modulator of tnf/ngf superfamily receptors and soluble oligomeric tnf/ngf superfamily receptors |
| 03/05/1997 | EP0759983A1 Dna encoding the beta subunit of a mammalian "maxi-k" potassium channel |
| 03/05/1997 | EP0759982A1 Extraction of heterologous insoluble proteins from bacteria |
| 03/05/1997 | EP0759981A1 A method of cultivating bacteria producing proteins that are expressed in a temperature regulated manner |
| 03/05/1997 | EP0759980A1 Interleukin-6 splice variant |
| 03/05/1997 | EP0759978A1 Neurotransmitter transporter |
| 03/05/1997 | EP0759944A1 Improvements in or relating to peptide delivery |